Literature DB >> 300361

Isolation of the capsular polysaccharide from culture supernatant of Haemophilus influenzae type b.

P Anderson, D H Smith.   

Abstract

The capsular polysaccharide (CP) of Haemophilus influenzae type b is known to be spontaneously released from the cells in culture. The CP is precipitable from culture supernatant by the cationic detergent hexadecyltrimethylammonium. Most of the nucleic acid and some of the protein, but almost none of the endotoxin, in the supernatant are co-precipitated. Extraction of the precipitate with progressively stronger NaCl solutions separates nucleic acid and protein from the CP and also effects a molecular size fractionation. Residual endotoxin and protein can be reduced by extraction with cold phenol and ultracentrifugation. The resulting preparation has ribose, ribitol, and phosphate as principal components and contains less than 1% other sugars, protein, or nucleic acid; it elutes on Sepharose 2B as a symmetrical peak with Kav 0.51.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 300361      PMCID: PMC421392          DOI: 10.1128/iai.15.2.472-477.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  ACIDIC POLYSACCHARIDE ANTIGENS OF A NEW TYPE FROM E. COLI CAPSULES.

Authors:  I ORSKOV; F ORSKOV; B JANN; K JANN
Journal:  Nature       Date:  1963-10-12       Impact factor: 49.962

2.  Studies on fractionated heparin.

Authors:  T C LAURENT
Journal:  Arch Biochem Biophys       Date:  1961-02       Impact factor: 4.013

3.  Aliphatic ammonium salts in the assay of acidic polysaccharides from tissues.

Authors:  J E SCOTT
Journal:  Methods Biochem Anal       Date:  1960

4.  Polyribophosphate, the type-specific substance of Hemophilus influenzae, type b.

Authors:  S ZAMENHOF; G LEIDY; P L FITZGERALD; H E ALEXANDER; E CHARGAFF
Journal:  J Biol Chem       Date:  1953-08       Impact factor: 5.157

5.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

6.  A method for the determination of heparin in blood.

Authors:  L B JAQUES; F C MONKHOUSE; M STEWART
Journal:  J Physiol       Date:  1949-08       Impact factor: 5.182

7.  Nonspecificity of the limulus amebocyte lysate test: positive reactions with polynucleotides and proteins.

Authors:  R J Elin; S M Wolff
Journal:  J Infect Dis       Date:  1973-09       Impact factor: 5.226

8.  Quantitative measurement of "natural" and immunization-induced Haemophilus influenzae type b capsular polysaccharide antibodies.

Authors:  J B Robbins; J C Parke; R Schneerson; J K Whisnant
Journal:  Pediatr Res       Date:  1973-03       Impact factor: 3.756

9.  Polyribitol-phosphate: an antigen of four gram-positive bacteria cross-reactive with the capsular polysaccharide of haemophilus influenzae type B.

Authors:  M Argaman; T Y Liu; J B Robbins
Journal:  J Immunol       Date:  1974-02       Impact factor: 5.422

10.  Capsular polymer of Haemophilus influenzae, type b. I. Structural characterization of the capsular polymer of strain Eagan.

Authors:  R M Crisel; R S Baker; D E Dorman
Journal:  J Biol Chem       Date:  1975-07-10       Impact factor: 5.157

View more
  12 in total

1.  Capsulation and gene copy number at the cap locus of Haemophilus influenzae type b.

Authors:  J S Kroll; E R Moxon
Journal:  J Bacteriol       Date:  1988-02       Impact factor: 3.490

2.  Multiple mechanisms in serum factor-induced resistance of Haemophilus influenzae type b to antibody.

Authors:  M Kuratana; E J Hansen; P Anderson
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

3.  Serotype specificity and immunogenicity of the capsular polymer of Haemophilus pleuropneumoniae serotype 5.

Authors:  T J Inzana; B Mathison
Journal:  Infect Immun       Date:  1987-07       Impact factor: 3.441

4.  Purification and partial characterization of the capsular polymer of Haemophilus pleuropneumoniae serotype 5.

Authors:  T J Inzana
Journal:  Infect Immun       Date:  1987-07       Impact factor: 3.441

5.  Clinical studies of a new latex particle agglutination test for detection of Haemophilus influenzae type b polyribose phosphate antigen in serum, cerebrospinal fluid, and urine.

Authors:  E D Shaw; R J Darker; W E Feldman; B M Gray; L L Pifer; G B Scott
Journal:  J Clin Microbiol       Date:  1982-06       Impact factor: 5.948

6.  Antibody responses to Haemophilus influenzae type b and diphtheria toxin induced by conjugates of oligosaccharides of the type b capsule with the nontoxic protein CRM197.

Authors:  P Anderson
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

7.  Efficacy of human hyperimmune globulin in prevention of Haemophilus influenzae type b disease in infant rats.

Authors:  D Ambrosino; J R Schreiber; R S Daum; G R Siber
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

8.  Immunogens consisting of oligosaccharides from the capsule of Haemophilus influenzae type b coupled to diphtheria toxoid or the toxin protein CRM197.

Authors:  P Anderson; M E Pichichero; R A Insel
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

9.  Evidence for covalent attachment of phospholipid to the capsular polysaccharide of Haemophilus influenzae type b.

Authors:  J S Kuo; V W Doelling; J F Graveline; D W McCoy
Journal:  J Bacteriol       Date:  1985-08       Impact factor: 3.490

10.  Pathophysiology of hemolysis in infections with Hemophilus influenzae type b.

Authors:  S B Shurin; P Anderson; J Zollinger; R K Rathbun
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.